Sodium cation

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Sodium cation
DrugBank Accession Number
DB14516
Background

Not Available

Type
Small Molecule
Groups
Experimental
Structure
Weight
Average: 22.9898
Monoisotopic: 22.989769675
Chemical Formula
Na
Synonyms
  • Sodium (ion)
  • Sodium ion
  • sodium(1+)

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
DrugInteraction
AcetazolamideThe risk or severity of dehydration can be increased when Acetazolamide is combined with Sodium cation.
AclidiniumThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Aclidinium.
AlfentanilThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Alfentanil.
AlloinThe risk or severity of adverse effects can be increased when Sodium cation is combined with Alloin.
AlmasilateThe therapeutic efficacy of Sodium cation can be decreased when used in combination with Almasilate.
Food Interactions
Not Available

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Mixture Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
Acetolyt - GranulatSodium cation (7.5 mmol) + Calcium (7.5 mmol) + Citric acid (8.75 mmol)Granule, for solutionOralMedicopharm Gmb H1972-09-15Not applicableAustria flag
AMINOMIXSodium cation (50 mmol/l) + Acetic acid (4.5 g/1000ml) + Alanine (7 g/1000ml) + Arginine (6 g/1000ml) + Calcium chloride dihydrate (0.294 g/100ml) + Dextrose, unspecified form (120 g/100ml) + Glycine (5.5 g/1000ml) + Histidine (1.5 g/1000ml) + Hydrochloric acid (1.47 ml) + Isoleucine (2.5 g/1000ml) + Leucine (3.7 g/1000ml) + Lysine (3.3 g/1000ml) + Magnesium chloride hexahydrate (0.61 g/100ml) + Methionine (2.15 g/1000ml) + Phenylalanine (2.55 g/1000ml) + Potassium cation (30 mmol/l) + Potassium hydroxide (1.981 g/100ml) + Proline (5.6 g/1000ml) + Serine (3.25 g/1000ml) + Sodium chloride (1.169 g/100ml) + Sodium glycerophosphate hydrate (4.59 g/1000ml) + Taurine (0.5 g/1000ml) + Threonine (2.2 g/1000ml) + Tryptophan (1 g/1000ml) + Tyrosine (0.2 g/1000ml) + Valine (3.1 g/1000ml) + Zinc chloride (0.00545 g/100ml)Injection, solutionIntravenousFresenius Kabi Italia S.R.L.2014-07-08Not applicableItaly flag
AMINOMIXSodium cation (50 mmol/l) + Acetic acid (4.5 g/1000ml) + Alanine (7 g/1000ml) + Arginine (6 g/1000ml) + Calcium chloride dihydrate (0.294 g/100ml) + Dextrose, unspecified form (200 g/100ml) + Glycine (5.5 g/1000ml) + Histidine (1.5 g/1000ml) + Hydrochloric acid (1.47 ml) + Isoleucine (2.5 g/1000ml) + Leucine (3.7 g/1000ml) + Lysine (3.3 g/1000ml) + Magnesium chloride hexahydrate (0.61 g/100ml) + Methionine (2.15 g/1000ml) + Phenylalanine (2.55 g/1000ml) + Potassium cation (30 mmol/l) + Potassium hydroxide (1.981 g/100ml) + Proline (5.6 g/1000ml) + Serine (3.25 g/1000ml) + Sodium chloride (1.169 g/100ml) + Sodium glycerophosphate hydrate (4.59 g/1000ml) + Taurine (0.5 g/1000ml) + Threonine (2.2 g/1000ml) + Tryptophan (1 g/1000ml) + Tyrosine (0.2 g/1000ml) + Valine (3.1 g/1000ml) + Zinc chloride (0.00545 g/100ml)Injection, solutionIntravenousFresenius Kabi Italia S.R.L.2014-07-08Not applicableItaly flag
AMINOMIXSodium cation (50 mmol/l) + Acetic acid (4.5 g/1000ml) + Alanine (7 g/1000ml) + Arginine (6 g/1000ml) + Calcium chloride dihydrate (0.294 g/100ml) + Dextrose, unspecified form (120 g/100ml) + Glycine (5.5 g/1000ml) + Histidine (1.5 g/1000ml) + Hydrochloric acid (1.47 ml) + Isoleucine (2.5 g/1000ml) + Leucine (3.7 g/1000ml) + Lysine (3.3 g/1000ml) + Magnesium chloride hexahydrate (0.61 g/100ml) + Methionine (2.15 g/1000ml) + Phenylalanine (2.55 g/1000ml) + Potassium cation (30 mmol/l) + Potassium hydroxide (1.981 g/100ml) + Proline (5.6 g/1000ml) + Serine (3.25 g/1000ml) + Sodium chloride (1.169 g/100ml) + Sodium glycerophosphate hydrate (4.59 g/1000ml) + Taurine (0.5 g/1000ml) + Threonine (2.2 g/1000ml) + Tryptophan (1 g/1000ml) + Tyrosine (0.2 g/1000ml) + Valine (3.1 g/1000ml) + Zinc chloride (0.00545 g/100ml)Injection, solutionIntravenousFresenius Kabi Italia S.R.L.2014-07-08Not applicableItaly flag
AMINOMIXSodium cation (50 mmol/l) + Acetic acid (4.5 g/1000ml) + Alanine (7 g/1000ml) + Arginine (6 g/1000ml) + Calcium chloride dihydrate (0.294 g/100ml) + Dextrose, unspecified form (120 g/100ml) + Glycine (5.5 g/1000ml) + Histidine (1.5 g/1000ml) + Hydrochloric acid (1.47 ml) + Isoleucine (2.5 g/1000ml) + Leucine (3.7 g/1000ml) + Lysine (3.3 g/1000ml) + Magnesium chloride hexahydrate (0.61 g/100ml) + Methionine (2.15 g/1000ml) + Phenylalanine (2.55 g/1000ml) + Potassium cation (30 mmol/l) + Potassium hydroxide (1.981 g/100ml) + Proline (5.6 g/1000ml) + Serine (3.25 g/1000ml) + Sodium chloride (1.169 g/100ml) + Sodium glycerophosphate hydrate (4.59 g/1000ml) + Taurine (0.5 g/1000ml) + Threonine (2.2 g/1000ml) + Tryptophan (1 g/1000ml) + Tyrosine (0.2 g/1000ml) + Valine (3.1 g/1000ml) + Zinc chloride (0.00545 g/100ml)Injection, solutionIntravenousFresenius Kabi Italia S.R.L.2014-07-08Not applicableItaly flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
NinePercentSodium cation (90 g/1000g)Injection, solutionIntravenousUS Specialty Formulations LLC2014-12-01Not applicableUS flag

Categories

Drug Categories
Classification
Not classified
Affected organisms
Not Available

Chemical Identifiers

UNII
LYR4M0NH37
CAS number
17341-25-2
InChI Key
FKNQFGJONOIPTF-UHFFFAOYSA-N
InChI
InChI=1S/Na/q+1
IUPAC Name
sodium(1+) ion
SMILES
[Na+]

References

General References
Not Available
Human Metabolome Database
HMDB0000588
KEGG Compound
C01330
ChemSpider
899
RxNav
1364429
ChEBI
29101
PDBe Ligand
NA
PDB Entries
131d / 191d / 192d / 193l / 194l / 1a2c / 1a3d / 1a46 / 1a4w / 1a50
show 11470 more

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
Granule, for solutionOral
Injection, solutionIntravenous
SuspensionOral
Tablet, chewableOral
Injection, powder, for solutionIntravenous
Tablet, delayed releaseOral
Injection, solutionIntravenous90 g/1000g
Injection, emulsionIntravenous
EmulsionIntravenous
SolutionIntraperitoneal
SolutionIntravenous100.000 mL
SolutionIntravenous50.000 mL
SolutionIntravenous
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
logP-0.77Chemaxon
pKa (Strongest Acidic)3.09Chemaxon
Physiological Charge1Chemaxon
Hydrogen Acceptor Count0Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area0 Å2Chemaxon
Rotatable Bond Count0Chemaxon
Refractivity0 m3·mol-1Chemaxon
Polarizability1.78 Å3Chemaxon
Number of Rings0Chemaxon
Bioavailability1Chemaxon
Rule of FiveYesChemaxon
Ghose FilterNoChemaxon
Veber's RuleYesChemaxon
MDDR-like RuleNoChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
Not Available
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-108.04653
predicted
DeepCCS 1.0 (2019)
[M+H]+109.77024
predicted
DeepCCS 1.0 (2019)
[M+Na]+116.600815
predicted
DeepCCS 1.0 (2019)

Drug created at July 12, 2018 16:35 / Updated at June 17, 2022 22:42